SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-20-024754
Filing Date
2020-09-01
Accepted
2020-09-01 15:34:08
Documents
1
Period of Report
2020-09-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1592
  Complete submission text file 0001213900-20-024754.txt   2957
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020 212 474 6700
CM Life Sciences, Inc. (Issuer) CIK: 0001818331 (see all company filings)

IRS No.: 851966622 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address
Emes Brian (Reporting) CIK: 0001822278 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39482 | Film No.: 201154384